{"result": "(\"entity\"<|>EDITORIAL MASSON SA<|>ORGANIZATION<|>Editorial Masson SA is a publishing company involved in the dissemination of medical literature and guidelines.)\n##\n(\"entity\"<|>AMERICAN PSYCHIATRIC ASSOCIATION<|>ORGANIZATION<|>The American Psychiatric Association is a professional organization that publishes the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and provides guidelines for mental health treatment.)\n##\n(\"entity\"<|>ANOREXIA NERVOSA<|>EVENT<|>Anorexia nervosa is an eating disorder characterized by an intense fear of gaining weight and a distorted body image, leading to restricted food intake and severe weight loss.)\n##\n(\"entity\"<|>BULIMIA NERVOSA<|>EVENT<|>Bulimia nervosa is an eating disorder marked by binge eating followed by purging, often associated with feelings of shame and guilt.)\n##\n(\"entity\"<|>OSTEOPOROSIS<|>EVENT<|>Osteoporosis is a medical condition characterized by weakened bones, increasing the risk of fractures, often seen in patients with eating disorders like anorexia nervosa.)\n##\n(\"entity\"<|>J CLIN ENDOCRINOL METAB<|>ORGANIZATION<|>J Clin Endocrinol Metab is a medical journal that publishes research related to endocrinology and metabolism, including studies on eating disorders.)\n##\n(\"relationship\"<|>EDITORIAL MASSON SA<|>AMERICAN PSYCHIATRIC ASSOCIATION<|>Editorial Masson SA publishes guidelines and literature that may include works from the American Psychiatric Association<|>4)\n##\n(\"relationship\"<|>ANOREXIA NERVOSA<|>OSTEOPOROSIS<|>Anorexia nervosa can lead to osteoporosis due to malnutrition and lack of essential nutrients<|>8)\n##\n(\"relationship\"<|>BULIMIA NERVOSA<|>OSTEOPOROSIS<|>Bulimia nervosa can also contribute to osteoporosis due to nutritional deficiencies and purging behaviors<|>6)\n##\n(\"relationship\"<|>AMERICAN PSYCHIATRIC ASSOCIATION<|>ANOREXIA NERVOSA<|>The American Psychiatric Association provides diagnostic criteria and treatment guidelines for anorexia nervosa<|>9)\n##\n(\"relationship\"<|>AMERICAN PSYCHIATRIC ASSOCIATION<|>BULIMIA NERVOSA<|>The American Psychiatric Association provides diagnostic criteria and treatment guidelines for bulimia nervosa<|>9)\n##\n(\"relationship\"<|>J CLIN ENDOCRINOL METAB<|>ANOREXIA NERVOSA<|>J Clin Endocrinol Metab publishes research studies related to the treatment and effects of anorexia nervosa<|>7)\n##\n(\"relationship\"<|>J CLIN ENDOCRINOL METAB<|>BULIMIA NERVOSA<|>J Clin Endocrinol Metab publishes research studies related to the treatment and effects of bulimia nervosa<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: idad, Barcelona, Editorial Masson SA,\nen sujetos con mejor estado nutricional, como reco-                                2001: 61-75.\nmienda la Sociedad de Medicina de Salud de Adoles-\ncentes recientemente48. Ello conducirá a una disminu-                          8.  Yager J, Devlin MJ, Halmi KA, Herzog DB, Mitchell\n                                                                                   JE, Powers P, et al. Practice guideline for the treat-\nción de los días de ingreso hospitalario en muchos                                 ment of patients with eating disorders. Third edi-\ncasos49, 50. También parece que la utilización de dietas                           tion. Washington, DC: American Psychiatric Asso-\ncon menor carga de hidratos de carbono (< 40 % ca-                                 ciation; 2006.\nlorías totales), en administración continua y con una                          9.  Mehler PS, Krantz MJ, Sachs KV. Treatments of\nadecuada suplementación de P y K, podría disminuir el                              medical complications of anorexia nervosa and\nriesgo de síndrome de realimentación51, 52.                                        bulimis nervosa. J Eating Disorders 2015; 3: 15.\n                                                                             10.   Temprano JL, Bretón I, Cuerda C, Camblor M, Gar-\n7.   Resumen                                                                       cía Peris P. Síndrome de realimentación. Rev Clin\n                                                                                   Esp 2005; 205: 79-86.\n   Los TCA son una patología frecuente en nuestros                           11.   Zipfel S, Seibel MJ, Löwe B, Beumont PJ, Kasperk\ndías, principalmente entre los adolescentes y jóvenes.                             C, Herzog W. Osteoporosis in eating disorders: a\nEs importante el diagnóstico y tratamiento precoz de                               follow-up study of patients with anorexia and bu-\nestos pacientes, ya que con frecuencia se cronifican y                             limia nervosa. J Clin Endocrinol Metab 2001; 86:\nocasionan secuelas físicas irreversibles (osteoporosis,                            5227-33.\netc.). El tratamiento nutricional resulta fundamental                        12.   Misra M, Klibanski A. Anorexia nervosa and bone.\nen el manejo de la AN, ya que estos pacientes suelen                               J Endocrinol 2014; 221: r163-176.\npresentar frecuentemente desnutrición, siendo nece-                          13.   Mehler PS, Mackenzie TD. Treatment of osteope-\nsario prevenir la aparición de síndrome de realimenta-                             nia and osteoporosis in anorexia nervosa: a syste-\nción. Por el contrario, en los pacientes con BN los tra-                           matic review of the literature. Int J Eat Disord\ntamientos      más     eficaces    son   la  psicoterapia      y   los             2009; 42: 195-201.\npsicofármacos.                                                               14.   Misra M, Katzman D, Miller KK, Mendes N, Snel-\n                                                                                   grove D, Russell M, et al. Physiologic estrogen re-\n8.   Bibliografía                                                                  placement increases bonde density in adolescent\n                                                                                   girls with anorexia nervosa. J Bone Miner Res\n  1.  American Psychiatric Association. Diagnostic and                             2011; 26: 2430-8.\n      statistical manual of mental disorders, fifth edition                  15.   Grinspoon S, Thomas L, Miller K, Herzog D, Kli-\n      (DSM-5). Arlington, VA: American Psychiatric As-                             banski A. Effects of recombinant human IGF-I and\n      sociation; 2013.                                                             oral contraceptive administration on bone density\n---\n 166      BLOQUE: ALTERACIONES DE LA ENERGÍA\n\n\n\n      in anorexia nervosa. J Clin Endocrinol Metab 2002;          30.  Fonseca VA, D’Souza V, Houlder S, Thoma M,\n      87: 2883-91.                                                     Wakeling A, Dandona P. Vitamin D deficiency and\n16.   Miller KK, Grieco KA, Klibanski A. Testosterone ad-              low osteocalcin concentrations in anorexia nervo-\n      ministration in women with anorexia nervosa. J                   sa. Clin Pathol 1988; 41: 195-7.\n      Clin Endocrinol Metab 2005; 90(3): 1428-33.                 31.  Cuerda C, Ruiz A, Moreno C, Iriondo MT, Velasco\n17.   Golden NH, Iglesias EA, Jacobson MS, Carey D,                    C, Bretón I, Camblor M, García Peris P. Estudio del\n      Meyer W, Schebendach J, eta al. Alendronate for                  gasto energético en la anorexia nerviosa: concor-\n      the treatment of osteopenia in anorexia nervosa: a               dancia entre calorimetría indirecta y diferentes\n      randomized,         double-blind,       placebo-controlled       ecuaciones. Nutr Hosp. 2005; 20(6): 371-7.\n      trial. J Clin Endocrin\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}